1.	A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NICHD Protocol IDs: PPRU 10762, NCT00491946
2.	Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: PSCI-2003-232, NCT00084695
3.	Radiation Therapy to Treat Musculoskeletal Tumors Phase: Phase II Type: Treatment Status: Active Age: 25 and under Sponsor: Other Protocol IDs: RTSARC, NCT00186992
4.	Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 100 Sponsor: Other Protocol IDs: EPROST-20110462, NCT01803152
5.	Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 50 Sponsor: NCI Protocol IDs: NCI-2011-02005, ARST08P1, CDR0000663937, COG-ARST08P1, U10CA098543, NCT01055314
6.	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases Phase: No phase specified Type: Treatment Status: Active Age: 1 to 29 Sponsor: NCI, Other Protocol IDs: Lung IMRT, NCT01586104